Novozymes Free Cash Flow 2011-2023 | NVZMY

Novozymes free cash flow for the twelve months ending December 31, 2023 was , a year-over-year.

  • Novozymes annual free cash flow for 2023 was $0.334B, a 84.96% increase from 2022.
  • Novozymes annual free cash flow for 2022 was $0.18B, a 63.6% decline from 2021.
  • Novozymes annual free cash flow for 2021 was $0.496B, a 9.26% decline from 2020.

Novozymes Free Cash Flow 2011-2023 | NVZMY

  • Novozymes annual free cash flow for 2023 was $0.334B, a 84.96% increase from 2022.
  • Novozymes annual free cash flow for 2022 was $0.18B, a 63.6% decline from 2021.
  • Novozymes annual free cash flow for 2021 was $0.496B, a 9.26% decline from 2020.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$197.2B
Sherwin-Williams (SHW)$83.9B
Ecolab (ECL)$65.4B
PPG Industries (PPG)$26.8B
International Flavors & Fragrances (IFF)$21.2B
Celanese (CE)$7.5B
Axalta Coating Systems (AXTA)$7.3B
Element Solutions (ESI)$6.1B
CSW Industrials (CSWI)$5.9B
Croda (COIHY)$5.8B
Arcadium Lithium (ALTM)$5.6B
Balchem (BCPC)$5.2B
NewMarket (NEU)$4.9B
Nissan Chemical (NNCHY)$4.4B
H B Fuller (FUL)$3.4B
Ashland (ASH)$3.3B
Sensient Technologies (SXT)$3B
Hawkins (HWKN)$2.5B
Quaker Houghton (KWR)$2.4B
Minerals Technologies (MTX)$2.4B
Perimeter Solutions, SA (PRM)$1.9B
Orbia Advance, S.A.B De C.V (MXCHY)$1.6B
Ingevity (NGVT)$1.4B
DAQO New Energy (DQ)$1.3B
ELEMENTIS (ELMTY)$1.1B
Huabao Holdings (HUIHY)$943M
Orion S.A (OEC)$881M
Westlake Chemical Partners LP (WLKP)$810M
AdvanSix (ASIX)$739M
Green Plains (GPRE)$641M